Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model [PDF]
Vojnosanitetski Pregled, 2015 Background/Aim. The widely accepted Follicular Lymphoma International Prognostic Index (FLIPI) divides patients into three risk groups based on the score of adverse prognostic factors.
Anđelić Boško +5 more
doaj +1 more source
Locally advanced breast cancer in younger women [PDF]
Archive of Oncology, 2003 Background: Standard treatment of locally advanced breast cancer is not yet established. In most institutions treatment is multimodal and consists of primary chemotherapy, surgical treatment with or without radiotherapy (RT) and hormonal therapy. To find
Lakićević Jadranka +2 more
doaj +1 more source
Clinical efficacy of neoadjuvant FAC chemotherapy in locally advanced breast cancer patients [PDF]
Archive of Oncology, 2003 Background: FAC chemotherapy (CT) regimen is a well-established standard in the neo-adjuvant or primary chemotherapy for locally advanced breast cancer (LABC) treatment.
Ždrale Zdravko +4 more
doaj +1 more source
Drug repurposing in oncology: a systematic review of randomized controlled clinical trials [PDF]
, 2023 Quality pharmacological treatment can improve survival in many types of cancer. Drug repurposing offers advantages in comparison with traditional drug development procedures, reducing time and risk.
Aza-Pascual-Salcedo, Mercedes +10 more
core +1 more source
Combined chemotherapy and irradiation in anaplastic thyroid carcinoma [PDF]
Archive of Oncology, 2003 Background: Anaplastic thyroid carcinoma (ATC) is a very rare and extremely aggressive cancer; patient's death usually occurs rapidly after diagnosis with a mean survival of six months in the majority of individual research series.
Pejčić Ivica +2 more
doaj +1 more source
Chemotherapy options for metastatic colorectal carcinoma: First, second, third line... [PDF]
Archive of Oncology, 2003 For almost 40 years, the only option for patients with unresectable metastases was treatment with 5-fluorouracil. In the last decade, new drugs became available that changed attitude toward treatment of metastatic CRC as well as the prognosis for some ...
Tomašević Zorica I. +3 more
doaj +1 more source
Advances in systemic treatment of metastatic gastric cancer [PDF]
Archive of Oncology, 2003 Gastric carcinoma is a frequent malignancy throughout the world and endemic in many of its regions. Advanced gastric carcinoma is often diagnosed. Patients with advanced gastric cancer have a median survival of 6-8 months and chemotherapy is palliative ...
Popov Ivan +3 more
doaj +1 more source
Systemic therapy for colorectal cancer [PDF]
Archive of Oncology, 2003 Colorectal cancer alone accounts for around 200,000 deaths in Europe and represents a significant health problem. Although about fifty percent of patients are cured by surgery alone, the other half will eventually die due to metastatic disease, which ...
Štabuc Borut
doaj +1 more source
The role of chemotherapy in the management of resectable colorectal cancer [PDF]
Archive of Oncology, 2003 Adjuvant chemotherapy has been established as the standard of care for patients with node-positive resected colon cancer. 5-fluorouracil modulated with leucovorin given for six months is currently the most widely accepted "standard" regimen.
Radosavljević Davorin Z. +3 more
doaj +1 more source
Vasopressin Analog [V4Q5]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models [PDF]
, 2023 Background: Colorectal cancer (CRC) is a leading cause of cancerassociated mortality worldwide. Despite being an essential component of systemic chemotherapy for advanced CRC, 5-fluorouracil (5-FU) clinical use has severe limitations, such as high ...
Alonso, Daniel Fernando +4 more
core +1 more source